[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590277":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":32,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":51,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Medical University Innsbruck","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Thomas Sonnweber, MD, PhD","CONTACT","+43(0)51250482586","Thomas.Sonnweber@i-med.ac.at",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"David Haschka, MD, PhD","david.haschka@i-med.ac.at",[18],{"facility":5,"status":19,"city":20,"state":21,"zip":22,"country":21,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"RECRUITING","Innsbruck","Austria","6020",{"type":24,"coordinates":25},"Point",[26,27],11.39454,47.26266,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":31,"phoneExt":7,"email":13},"+43(0)501250482586",{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100590277",false,"NCT06965322","Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis","Prospective Observational Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis","REASSESS","Inclusion Criteria:\n\n* Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR\u002FEULAR criteria\n* Residence in Austria\n* Signed and dated consent of the patient in accordance with ICH-GCP guidelines\n\nExclusion Criteria:\n\n* pregnancy\n* age below 18 years\n* Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)","ALL","18 Years",{"count":44,"type":45},800,"ESTIMATED","OBSERVATIONAL","The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).",[49,50],"Rheumatic Arthritis","Interstitial Lung Disease in Patients With Rheumatoid Arthritis",[52,53,54,55],"rheumatoid arthritis","interstitial lung disease","risk prediction","RA-ILD","2025-12-01",{"date":58,"type":59},"2025-12-02","ACTUAL",{"date":61,"type":59},"2024-11-11",{"date":63,"type":45},"2029-09-30",{"name":5,"class":6},1]